99 related articles for article (PubMed ID: 16612149)
1. [Altered fractionation].
Hasegawa M; Nishio M; Myoujin M; Nishiyama N; Ichimura W
Gan To Kagaku Ryoho; 2006 Apr; 33(4):428-35. PubMed ID: 16612149
[TBL] [Abstract][Full Text] [Related]
2. [Accelerated fractionation regimens in radiotherapy of inoperable non-small-cell lung cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM; Kudriavtsev LV; Akishin VA
Vopr Onkol; 2003; 49(5):647-51. PubMed ID: 14682141
[TBL] [Abstract][Full Text] [Related]
3. [Accelerated fractionation].
Shibayama C; Nakazawa M; Nakamura M; Akahane K; Takahashi S; Kashima E
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1837-41. PubMed ID: 19011332
[TBL] [Abstract][Full Text] [Related]
4. [Fractionation and radiation injury--clinical aspect].
Kikuchi Y; Saito Y; Nishino S; Uekita Y
Gan No Rinsho; 1990 Oct; 36(13):2337-47. PubMed ID: 2250355
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
Stuschke M; Thames HD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
[TBL] [Abstract][Full Text] [Related]
6. Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
Shuryak I; Hall EJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):272-278. PubMed ID: 30776451
[TBL] [Abstract][Full Text] [Related]
7. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
8. [Controlled clinical trials of hyperfractionated and accelerated radiotherapy in otorhinolaryngologic cancers].
Horiot JC
Bull Acad Natl Med; 1998; 182(6):1247-60; discussion 1261. PubMed ID: 9812410
[TBL] [Abstract][Full Text] [Related]
9. [Choice of fractionation regimen in radiotherapy of inoperable esophageal cancer].
Val'kov MIu; Zolotkov AG; Mardynskiĭ IuS; Asakhin SM
Vopr Onkol; 2003; 49(5):651-6. PubMed ID: 14682142
[TBL] [Abstract][Full Text] [Related]
10. Altered fractionation trials in head and neck cancer.
Ang KK
Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100
[TBL] [Abstract][Full Text] [Related]
11. Hyperfractionation: where do we stand?
Beck-Bornholdt HP; Dubben HH; Liertz-Petersen C; Willers H
Radiother Oncol; 1997 Apr; 43(1):1-21. PubMed ID: 9165132
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer: altered fractionation schedules.
Saunders MI
Oncologist; 1999; 4(1):11-6. PubMed ID: 10337367
[TBL] [Abstract][Full Text] [Related]
14. Altered fractionation for head and neck cancer.
Garden AS
Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
[TBL] [Abstract][Full Text] [Related]
15. [Dose-response relationship in radiotherapy: an evidence?].
Chauvet B; de Rauglaudre G; Mineur L; Alfonsi M; Reboul F
Cancer Radiother; 2003 Nov; 7 Suppl 1():8s-14s. PubMed ID: 15124539
[TBL] [Abstract][Full Text] [Related]
16. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
Marcu L; Bezak E
Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Bourhis J; Overgaard J; Audry H; Ang KK; Saunders M; Bernier J; Horiot JC; Le Maître A; Pajak TF; Poulsen MG; O'Sullivan B; Dobrowsky W; Hliniak A; Skladowski K; Hay JH; Pinto LH; Fallai C; Fu KK; Sylvester R; Pignon JP;
Lancet; 2006 Sep; 368(9538):843-54. PubMed ID: 16950362
[TBL] [Abstract][Full Text] [Related]
18. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary results of accelerated hyperfractionated split course radiotherapy of advanced head and neck cancers].
Miszczyk L; Woźniak G; Maciejewski B; Tarnawski R
Otolaryngol Pol; 2003; 57(6):785-92. PubMed ID: 15049176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
